EPS Bio Technology Corp. (TPEX:4183)

EPS Bio Technology Revenue

EPS Bio Technology had revenue of 105.58M TWD in the quarter ending June 30, 2026, a decrease of -18.96%. This brings the company's total for the last twelve months to 418.74M, down -10.81% year-over-year. In the year 2025, EPS Bio Technology had annual revenue of 499.70M with 10.78% growth. That makes EPS Bio Technology the 36,161st largest company in the world by revenue and 1,882nd in Taiwan.

• Revenue (ttm): 418.74M
• Revenue Growth: -10.81%
• P/S Ratio: 0.82
• Revenue / Employee: 3.88M
• Employees: 108
• Market Cap: 342.72M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Germany 206.87M 41.4%
• Iran 114.47M 22.9%
• Others 75.68M 15.1%
• Saudi Arabia 51.67M 10.3%
• United States 26.43M 5.3%
• Switzerland 24.60M 4.9%

Fiscal year ended Dec 31, 2025 See the full EPS Bio Technology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	499.70M	48.62M	10.78%
Dec 31, 2024	451.08M	-19.08M	-4.06%
Dec 31, 2023	470.17M	6.72M	1.45%
Dec 31, 2022	463.45M	-16.83M	-3.50%
Dec 31, 2021	480.28M	2.68M	0.56%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error